What is a barrier to appropriate treatment of pain in sickle cell disease?

• A. Fear of addiction by patients, families, and health care workers
• B. Insufficient opioid supply in all settings
• C. Lack of pain guidelines
• D. Insurance coverage is the sole barrier

Answer: (A)

The key issue is how fears and beliefs about opioids influence pain management in sickle cell disease. Fear of addiction among patients, families, and health care workers can drive under-treatment: clinicians may be hesitant to prescribe adequate opioid relief, patients may delay seeking care, and stigma can lead to dismissing legitimate pain. This dynamic often results in insufficient analgesia during painful crises, even when opioids are clinically appropriate. While other barriers like occasional supply issues, gaps in guidelines, or insurance hurdles exist, they don’t explain the pervasive impact of fear and stigma as directly as the worry about addiction does. Addressing this requires education about addiction risk, distinguishing between addiction and appropriate analgesia, and clear, patient-centered treatment protocols to ensure effective pain relief.